FBL and systemic sclerosis: We also analyzed the presence of anti-fibrillarin antibodies using the commercial Euroline Systemic Sclerosis Line Blot (Supplementary Figure S6) and found that 16 of 62 samples (25.8%) were positive and 46 (74.2%) were negative for anti-fibrillarin (Table 1).